Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Atrophic VaginitisMenopause
Interventions
DEVICE

CO2 fractionated vaginal laser

Intravaginal treatment with fractional microablative CO2 laser at baseline, 6 weeks and 3 months

DRUG

Estrogens, Conjugated (USP)

Conjugated estrogen cream 0.5g (equivalent of 0.625 mg of conjugated estrogen) daily for two weeks then twice weekly for 24 weeks

Trial Locations (6)

20010

Washington Hospital Center, Washington D.C.

27157

Wake Forest Baptist Medical Center, Winston-Salem

44195

Cleveland Clinic, Cleveland

45220

Christ Hospital, Cincinnati

94305

Stanford University, Stanford

02903

Brown Medical School, Providence

All Listed Sponsors
collaborator

Foundation for Female Health Awareness

OTHER

lead

The Cleveland Clinic

OTHER

NCT02691936 - Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy | Biotech Hunter | Biotech Hunter